SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-057274
Filing Date
2023-12-12
Accepted
2023-12-12 07:43:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A edge20015072x2_defa14a.htm DEFA14A 13126
2 edge20015072x2-noa1.jpg GRAPHIC 1903111
3 edge20015072x2-noa2.jpg GRAPHIC 1279808
  Complete submission text file 0001140361-23-057274.txt   4103024
Mailing Address 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035
Business Address 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38473 | Film No.: 231479969
SIC: 2834 Pharmaceutical Preparations